Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer
Go back to Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 86.55 +2.56 (3.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $83.99 | 52 Week High | $8.22 | |||
| Open | $84.59 | 52 Week Low | $3.07 | |||
| Day High | $87.83 | P/E | N/A | |||
| Day Low | $83.13 | EPS | $-1.30 | |||
| Volume | 2,441,341 | |||||
